WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003072117) DIALYZED LEUKOCYTE EXTRACT FOR THE TREATMENT OF INFECTIOUS DISEASES IN ANIMALS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/072117    International Application No.:    PCT/MX2003/000016
Publication Date: 04.09.2003 International Filing Date: 26.02.2003
Chapter 2 Demand Filed:    26.09.2003    
IPC:
A61K 35/14 (2006.01), A61K 35/26 (2006.01), A61K 35/28 (2006.01)
Applicants: CALZADA NOVA, Luis Antonio [MX/MX]; (MX)
Inventors: CALZADA NOVA, Luis Antonio; (MX)
Agent: GAYTAN GUZMAN, Patricia; Cerrada del Club No. 6, Fraccionamiento Villas Kent, Colonia La Asunción., 52140 Metepec, Estado de México (MX)
Priority Data:
PA/a/2002/002171 28.02.2002 MX
Title (EN) DIALYZED LEUKOCYTE EXTRACT FOR THE TREATMENT OF INFECTIOUS DISEASES IN ANIMALS
(ES) EXTRACTO DE LEUCOCITOS DIALIZADO PARA EL TRATAMIENTO DE ENFERMEDADES INFECCIOSAS EN ANIMALES
(FR) EXTRAIT DE LEUCOCYTES DIALYSE POUR LE TRAITEMENT DE MALADIES INFECTIEUSES CHEZ DES ANIMAUX
Abstract: front page image
(EN)The invention relates to a pharmacological compound which is made with the soluble dialyzed extract of leukocyte lysates of animal origin. Said leukocyte lysates are obtained from blood or lymphatic tissue from domestic animals which may or may not be sensitized with specific antigens. The inventive compound is intended to be applied to animals in order to treat infectious diseases, such as canine distemper.
(ES)La presente invención consiste en un compuesto farmacológico elaborado con el extracto soluble dializado de leucocitos lisados de origen animal, los cuales se obtienen de tejido sanguíneo o linfático de animales domésticos sensibilizados ó no sensibilizados con antígenos específicos para su aplicación en animales en el tratamiento de enfermedades infecciosas, tales como moquillo canino.
(FR)La présente invention concerne un composé pharmaceutique préparé avec l'extrait soluble dialysé de leucocytes lysés d'origine animale obtenus à partir d'un tissu sanguin ou lymphatique d'animaux domestiques sensibilisés ou non sensibilisés par des antigènes spécifiques. Ce composé pharmaceutique est appliqué à des animaux pour le traitement de maladies infectieuses, telles que la maladie de Carré.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Spanish (ES)
Filing Language: Spanish (ES)